
--- Page 1 ---
/cs-0-3 Cucinonu,infilrnHry,dutd,Nos 85otf3 S.tbsnst, Nos C5o.9 31fy page 1 / 2 Department of Cancer Pathology copy No. Date: Examination: Histopathological examination Internal invoice No.. Cost of diagnostic procedure Examination No.: Patient: xxx PESEL: XXX Age: Gender: F Material: 1. Multiple organ resection - right breast and axillary tissue Unit in charge: Physician in charge: Material collected on:. Material received on. Expected time of examination: up to 8 working days Clinical diagnosis: Cancer of the right breast. UUID:EF2DC6FB-F026-4025-B148-DF07194914AB0 TCGA-D8-A13I-01A-PR Redacted

--- Page 2 ---
Examination performed on. Macroscopic description: Right breast sized 35 x 23 x 9 cm removed along with axillary tissues sized 13 x 8 x 4 cm and a skin flap of 24 x 17 cm. Weight 1,400 g. Tumour sized 1.9 x 1.4 x 1.8 cm in the upper outer quadrant, 6 cm from the upper boundary, 2 cm from the  base and 1.8 cm from the front surface. Lymph nodes 2.4 cm in length. Microscopic description:d Carcinoma ductale invasivum - NHG1 (2 + 3 +1: 2 mitoses/ 10 HPF, visual area diameter 0.57 mm). Glandular tissue, outside the tumour, showing lesions of the type mastopathia fibrosa et cystica, hyperplasia ductalis simplex (ADH), adenosis sclerosans. AXILLARY LYMPH NODES: Metastases carcinomatosae in Iymphonodis (No It/xxI). Infiltratio capsulae lymphonodi et telae perinodalis. Emboliae carcinomatosae vasorum. Histopathological diagnosis: Carcinoma ductale invasivum mammae dextrae. Invasive ductal carcinoma of the left breast  Metastases carcinomatosae in lymphonodis axillae (No Il/xxil). Cancer metastases in axillary lymph nodes (No II/XXII) Invasivo carcinomatosa vasorum. Vascular invasion (NHG2, pT1c, pN1a). Compliance validated by: Results of immunohistochemical examination: Estrogen receptors found in 10-75% of neoplastic cell nuclei. Progesterone receptors found in over 75% of neoplastic cell nuclei. HER2 protein stained with HercepTestTM by DAKO. Negative reaction in invasive carcinoma cells ( Score = 1+ ) Compliance validated by:.